ZANOTTI, Laura
 Distribuzione geografica
Continente #
NA - Nord America 3.422
EU - Europa 1.329
AS - Asia 1.322
SA - Sud America 185
Continente sconosciuto - Info sul continente non disponibili 91
AF - Africa 34
OC - Oceania 4
Totale 6.387
Nazione #
US - Stati Uniti d'America 3.329
CN - Cina 445
SG - Singapore 409
PL - Polonia 367
IT - Italia 190
DE - Germania 177
UA - Ucraina 177
HK - Hong Kong 161
BR - Brasile 156
FI - Finlandia 101
VN - Vietnam 97
GB - Regno Unito 89
FR - Francia 65
CA - Canada 54
TR - Turchia 46
IN - India 36
RU - Federazione Russa 35
IE - Irlanda 34
BD - Bangladesh 31
SE - Svezia 18
ES - Italia 15
ID - Indonesia 15
IQ - Iraq 14
NL - Olanda 14
AR - Argentina 11
MX - Messico 11
ZA - Sudafrica 10
PK - Pakistan 9
JP - Giappone 8
CZ - Repubblica Ceca 7
KR - Corea 7
LT - Lituania 7
UZ - Uzbekistan 7
AT - Austria 6
BG - Bulgaria 6
EC - Ecuador 6
TW - Taiwan 6
AE - Emirati Arabi Uniti 5
BE - Belgio 5
CR - Costa Rica 5
MA - Marocco 5
NI - Nicaragua 5
SA - Arabia Saudita 5
JM - Giamaica 4
KG - Kirghizistan 4
NG - Nigeria 4
TT - Trinidad e Tobago 4
CL - Cile 3
KE - Kenya 3
MY - Malesia 3
PY - Paraguay 3
TN - Tunisia 3
AO - Angola 2
AU - Australia 2
CH - Svizzera 2
CO - Colombia 2
EG - Egitto 2
EU - Europa 2
GT - Guatemala 2
HN - Honduras 2
JO - Giordania 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LV - Lettonia 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GD - Grenada 1
GP - Guadalupe 1
IL - Israele 1
IR - Iran 1
LC - Santa Lucia 1
LU - Lussemburgo 1
LY - Libia 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
PR - Porto Rico 1
SC - Seychelles 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TO - Tonga 1
Totale 6.298
Città #
Warsaw 367
Ashburn 338
Fairfield 332
Singapore 245
Woodbridge 234
San Jose 191
Houston 175
Seattle 169
Hong Kong 142
Chandler 141
Jacksonville 133
Cambridge 117
New York 106
Wilmington 105
Beijing 101
Ann Arbor 93
Dearborn 92
Council Bluffs 77
Los Angeles 73
Helsinki 69
The Dalles 67
Princeton 62
Brescia 42
Nanjing 41
Munich 36
Dublin 34
Istanbul 32
Shanghai 30
Dallas 29
Lauterbourg 29
Chicago 26
San Francisco 26
Des Moines 25
Buffalo 21
Columbus 21
Santa Clara 21
São Paulo 21
Dong Ket 20
Jinan 20
Ho Chi Minh City 19
London 19
Milan 19
Toronto 19
Shenyang 16
Hanoi 14
Orem 14
Turku 14
Central 13
Changsha 13
Rome 13
Moscow 12
Nanchang 12
Phoenix 12
Hangzhou 11
Hebei 11
Chennai 10
Kunming 10
Belo Horizonte 9
Jiaxing 9
Redondo Beach 9
Stockholm 9
Tianjin 9
Denver 8
Jakarta 8
Montreal 8
North Bergen 8
Paris 8
Poplar 8
San Diego 8
Ankara 7
Boston 7
Brooklyn 7
Guangzhou 7
Miami 7
Falkenstein 6
Lanzhou 6
Monmouth Junction 6
Norwalk 6
Tashkent 6
Tokyo 6
Zhengzhou 6
Brno 5
Brussels 5
Hefei 5
Johannesburg 5
Lahore 5
Managua 5
Manchester 5
Mexico City 5
Mumbai 5
Sofia 5
Vienna 5
Abuja 4
Atlanta 4
Baghdad 4
Bishkek 4
Cape Town 4
Cazzago San Martino 4
Da Nang 4
Frankfurt am Main 4
Totale 4.419
Nome #
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2916-21. doi: 10.1073/pnas.1222577110. Epub 2013 Jan 28. Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma. Zhao S1, Choi M, Overton JD, Bellone S, Roque DM, Cocco E, Guzzo F, English DP, Varughese J, Gasparrini S, Bortolomai I, Buza N, Hui P, Abu-Khalaf M, Ravaggi A, Bignotti E, Bandiera E, Romani C, Todeschini P, Tassi R, Zanotti L, Carrara L, Pecorelli S, Silasi DA, Ratner E, Azodi M, Schwartz PE, Rutherford TJ, Stiegler AL, Mane S, Boggon TJ, Schlessinger J, Lifton RP, Santin AD 375
Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues 372
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery 302
Epidermal growth factor receptor detection in serum and saliva as a diagnostic and prognostic tool in oral cancer 223
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts 216
Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis. 209
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma 208
Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. 199
Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma 199
Altered immunolocalization of heat-shock proteins in human peri-implant gingiva 197
Identification of optimal reference genes for gene expression normalization in a wide cohort of endometrioid endometrial carcinoma tissues. 194
Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma 187
RERT: A Novel Regression Tree Approach to Predict Extrauterine Disease in Endometrial Carcinoma Patients 185
Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence 184
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis 181
Role of the novel generation of androgen receptor pathway targeted agents in the management of castration-resistant prostate cancer: A literature based meta-analysis of randomized trials 180
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition 180
A Phase Ib Open-Label Study to Assess the Safety and Tolerability of Everolimus in Combination with Eribulin in Triple-Negative Breast Cancers 175
Incidence and relative risk of adverse events of special interest in patients with castration resistant prostate cancer treated with CYP-17 inhibitors: A meta-analysis of published trials 170
Functional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: Implications for personalized cancer therapy 167
Claudin 7 downregulation is predictive of distant metastasis in high-grade serous carcinoma patients 160
The claudin-low subtype of high-grade serous ovarian carcinoma exhibits stem cell features 160
The HIV-protease inhibitor saquinavir reduces proliferation, invasion and clonogenicity in cervical cancer cell lines 158
Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome 155
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients 152
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer 151
Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients 130
FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients 126
Room-temperature gas sensing based on visible photoluminescence properties of metal oxide nanobelts 125
L1CAM expression as a predictor of platinum response in high-risk endometrial carcinoma 121
Oxide nanobelts as conductometric gas sensors 120
Gas sensitive light emission properties of tin oxide nanobelts 113
Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors 113
Infiltration by CXCL10 Secreting Macrophages Is Associated With Antitumor Immunity and Response to Therapy in Ovarian Cancer Subtypes 104
Circulating Serum Micro-RNA as Non-Invasive Diagnostic Biomarkers of Endometriosis 93
Development of a diagnostic model based on serum microRNAs for the diagnosis of endometriosis 68
Serum miRNA-based diagnostic models for endometriosis: from discovery to validation 35
Totale 6.387
Categoria #
all - tutte 28.153
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.153


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022230 0 0 0 4 1 15 24 16 11 46 43 70
2022/2023361 57 24 19 25 28 67 3 37 63 4 16 18
2023/2024457 26 11 46 33 23 111 23 36 75 26 8 39
2024/2025705 6 15 7 103 45 85 54 35 72 42 150 91
2025/20261.684 165 166 110 231 209 138 269 61 104 147 64 20
2026/2027406 70 63 99 174 0 0 0 0 0 0 0 0
Totale 6.387